Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc

Bullboard Posts

Comment by bashermasher1on Jan 14, 2015 9:24pm

125 Views

Post# 23321099

RE:Looking forward to Feb 15 2015

Hopefully There has been Lumisort news before then! If not sp will be lower then it is today. Any gain by q1 results will just bring sp back a little closer to .70 so what ends up happening is it is still lower. so there is no gain. you end up lower and lower and lower....hmmmmm.

Bullboard Posts

Soma Gold poised to extend profitable track record